EE257 Budget Consequences of Five Benign Prostatic Hyperplasia Treatment Options - US Medicare Perspective
Abstract
Authors
B Chughtai S Rojanasarot K Neeser D Gultyaev P Herscu S Fu SK Bhattacharyya A El-Arabi B Cutone KT McVary